Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-17

Clinical Trial Update: Post Operative Pain Management Through Adductor Canal Block With Bupivacaine for ACL Reconstruction [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for postoperative pain management in ACL reconstruction using adductor canal block with bupivacaine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)

Snippet

Sponsor: Rothman Institute Orthopaedics | Conditions: Pain, Postoperative, ACL | Phase 3 | Status: UNKNOWN